Physera is a US-based startup with a mission to provide a better way to treat and prevent pain. The company, founded in 2015, focuses on the health care industry and has gained attention with its innovative program for managing musculoskeletal (MSK) conditions. Utilizing a smartphone-based platform, Physera offers quick and easy access to virtual physical therapy. Patients receive personalized, guided exercise therapy by top-tier licensed physical therapists, leading to faster recovery, positive clinical outcomes, and a reduction of downstream MSK spend. Furthermore, Physera's approach not only improves access to physical therapy but also offers convenience, aligning with the demands of modern healthcare consumers. In March 2019, the company secured an $8.00M Series A investment from notable investors Expa and Blue Venture Fund, indicating confidence in Physera's vision and potential. This investment serves as recognition of Physera's impactful contribution to the health tech sector and signifies a promising trajectory for the company. With its strong value proposition and significant backing, Physera is poised to make a substantial impact in revolutionizing the approach to MSK treatment and paving the way for enhanced patient care.
No recent news or press coverage available for Physera.